[Erectile dysfunctions]

Orv Hetil. 2009 Jan 18;150(3):133-5. doi: 10.1556/OH.2009.28538.
[Article in Hungarian]
No abstract available

MeSH terms

  • Adrenergic alpha-Antagonists / therapeutic use
  • Apomorphine / therapeutic use
  • Diagnosis, Differential
  • Dopamine Agonists / therapeutic use
  • Erectile Dysfunction* / diagnosis
  • Erectile Dysfunction* / drug therapy
  • Erectile Dysfunction* / epidemiology
  • Erectile Dysfunction* / etiology
  • Erectile Dysfunction* / surgery
  • Humans
  • Impotence, Vasculogenic / diagnosis
  • Impotence, Vasculogenic / surgery
  • Male
  • Penile Implantation
  • Phosphodiesterase Inhibitors / therapeutic use
  • Risk Factors
  • Testosterone / administration & dosage
  • Testosterone / deficiency
  • Vascular Surgical Procedures
  • Yohimbine / therapeutic use

Substances

  • Adrenergic alpha-Antagonists
  • Dopamine Agonists
  • Phosphodiesterase Inhibitors
  • Yohimbine
  • Testosterone
  • Apomorphine